(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-1.01%) $83.00
(-1.16%) $1.619
(-0.41%) $2 337.50
(-0.42%) $27.42
(0.37%) $925.50
(-0.15%) $0.933
(-0.14%) $11.01
(-0.23%) $0.799
(0.00%) $92.17
Quarter results today
(bmo 2024-04-29)
Expected move: +/- 3.62%
Live Chart Being Loaded With Signals
Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products...
Stats | |
---|---|
Šios dienos apimtis | 49 903.00 |
Vidutinė apimtis | 89 387.00 |
Rinkos kapitalizacija | 3.26B |
EPS | INR0 ( 2024-04-21 ) |
Kita pelno data | ( INR0 ) 2024-04-29 |
Last Dividend | INR1.250 ( 2021-11-22 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 22.90 |
ATR14 | INR0.679 (0.26%) |
Tūris Koreliacija
Par Drugs and Chemicals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Par Drugs and Chemicals Koreliacija - Valiuta/Žaliavos
Par Drugs and Chemicals Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR950.95M |
Bruto pelnas: | INR286.90M (30.17 %) |
EPS: | INR9.21 |
FY | 2022 |
Pajamos: | INR950.95M |
Bruto pelnas: | INR286.90M (30.17 %) |
EPS: | INR9.21 |
FY | 2023 |
Pajamos: | INR0 |
Bruto pelnas: | INR0 (0.00 %) |
EPS: | INR0 |
FY | 2022 |
Pajamos: | INR742.00M |
Bruto pelnas: | INR243.36M (32.80 %) |
EPS: | INR7.49 |
Financial Reports:
No articles found.
Par Drugs and Chemicals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.625 | 2019-11-22 |
Last Dividend | INR1.250 | 2021-11-22 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | INR2.50 | -- |
Avg. Dividend % Per Year | 0.57% | -- |
Score | 2.03 | -- |
Div. Sustainability Score | 2.90 | |
Div.Growth Potential Score | 5.60 | |
Div. Directional Score | 4.25 | -- |
Year | Amount | Yield |
---|---|---|
2019 | INR0.625 | 1.25% |
2020 | INR0.625 | 1.42% |
2021 | INR1.250 | 3.54% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SESHAPAPER.NS | Dividend Junior | 2023-06-07 | Annually | 23 | 1.14% | |
MANAKCOAT.NS | Dividend Junior | 2023-08-22 | Sporadic | 4 | 0.09% | |
GOODYEAR.NS | Dividend Knight | 2023-07-26 | Annually | 5 | 4.02% | |
AVANTIFEED.NS | Dividend Junior | 2023-08-03 | Annually | 14 | 0.86% | |
TRIL.NS | Dividend Junior | 2023-07-27 | Sporadic | 17 | 0.22% | |
PILANIINVS.NS | Dividend Junior | 2023-08-29 | Annually | 13 | 0.56% | |
JKCEMENT.NS | Dividend Junior | 2023-08-01 | Annually | 19 | 0.37% | |
DEVIT.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.28% | |
SMSPHARMA.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.12% | |
MINDTECK.NS | Dividend Junior | 2023-08-04 | Sporadic | 8 | 0.28% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.147 | 1.500 | 7.06 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.190 | 1.500 | 9.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -446.64 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.48 | 2.00 | 5.51 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.27 | 2.00 | 4.86 | 9.73 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.299 | 1.000 | 8.34 | 8.34 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.194 | 1.000 | 8.13 | 8.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 22.91 | 1.000 | 7.79 | 0 | [1 - 100] |
returnOnEquityTTM | 0.190 | 2.50 | 9.36 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.27 | 2.00 | 6.58 | 9.73 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.48 | 2.00 | 5.51 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.998 | 1.500 | 6.68 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.172 | 1.000 | 8.21 | 0 | [0.1 - 0.5] |
Total Score | 5.60 |
Par Drugs and Chemicals
Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.